Related Experiment Video
Updated: May 12, 2026

Modeling Highly Repetitive Low-level Blast Exposure in Mice
Published on: May 24, 2024
Outcomes of persons with blastomycosis involving the central nervous system
Jonathan W Bush1, Terry Wuerz, John M Embil
1Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada.
Abstract:
Blastomyces dermatitidis is a dimorphic fungus which is potentially life-threatening if central nervous system (CNS) dissemination occurs. Sixteen patients with proven or probable CNS blastomycosis are presented. Median duration of symptoms was 90 days; headache and focal neurologic deficit were the most common presenting symptoms. Magnetic resonance imaging (MRI) consistently demonstrated an abnormality, compared to 58% of computed tomography scans. Tissue culture yielded the pathogen in 71% of histology-confirmed cases. All patients who completed treatment of an amphotericin B formulation and extended azole-based therapy did not relapse. Initial nonspecific symptoms lead to delayed diagnosis of CNS blastomycosis. A high index of suspicion is necessary if there is history of contact with an area where B. dermatitidis is endemic. Diagnostic tests should include MRI followed by biopsy for tissue culture and pathology. Optimal treatment utilizes a lipid-based amphotericin B preparation with an extended course of voriconazole.
Insights
Central nervous system (CNS) blastomycosis, a fungal infection, requires prompt diagnosis and treatment. Early recognition and appropriate therapy with amphotericin B and azoles can prevent relapse.
Area of Science:
- Mycology
- Infectious Diseases
- Neurology
Background:
- Blastomyces dermatitidis is a fungus that can cause life-threatening central nervous system (CNS) infections.
- CNS blastomycosis often presents with delayed diagnosis due to nonspecific symptoms.
Purpose of the Study:
- To present a series of patients with CNS blastomycosis.
- To review the clinical presentation, diagnostic methods, and treatment outcomes.
Main Methods:
- Retrospective review of 16 patients with proven or probable CNS blastomycosis.
- Analysis of clinical symptoms, diagnostic imaging (MRI, CT scans), tissue culture results, and treatment regimens.
Main Results:
- Median symptom duration was 90 days, with headache and focal neurologic deficits being common.
- MRI demonstrated abnormalities in all cases, while CT scans showed abnormalities in 58%.
- Tissue culture yielded Blastomyces dermatitidis in 71% of histology-confirmed cases.
Conclusions:
- A high index of suspicion is crucial for diagnosing CNS blastomycosis, especially in endemic areas.
- MRI followed by biopsy for tissue culture is recommended for diagnosis.
- Optimal treatment involves lipid-based amphotericin B and an extended course of voriconazole to prevent relapse.
Related Concept Videos
Arboviral Encephalitis
Brain Abscess l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

